{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:09:21Z","timestamp":1793225361143,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100024856","name":"Agricultural Research Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100024856","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The detection of Highly Pathogenic Avian Influenza (HPAI) A(H5N1) in dairy cattle in the United States has raised concerns about human exposure. This study evaluated the efficacy of various doses of an inactivated H5 AI vaccine in cattle and assessed antibody transfer in milk against a recent bovine isolate of HPAI A(H5N1, clade 2.3.4.4b). Calves were inoculated with different vaccine doses, while lactating cows received the vaccine four weeks later. The humoral immune response was measured using the Hemagglutination Inhibition (HI) test and ELISA. Results showed a dose-dependent immune response, with higher doses producing stronger and more sustained antibody levels. Group 1 maintained a stable HI titer of 6 log\n                    <jats:sub>2<\/jats:sub>\n                    , while Groups 2, 3, and 4 peaked at 8, 9, and 9 log\n                    <jats:sub>2<\/jats:sub>\n                    , respectively, by the fourth week post-vaccination. Milk antibody transfer was observed, with strong positive responses in milk samples by the second week post-vaccination. The ID Screen ELISA demonstrated higher sensitivity for detecting antibodies in milk compared to serum. The immune response to the AI vaccine differed from responses to other vaccines used in cattle such as Foot and Mouth Disease Virus (FMDV) and Lumpy Skin Disease Virus (LSDV), indicating the need for optimizing vaccine dosage and formulation, including adjuvant and antigen content. Future research should extend the monitoring period, increase sample sizes, and explore different vaccine formulations to develop effective vaccination strategies for cattle. These findings highlight the potential for using inactivated H5 AI vaccines in cattle to enhance immune protection and facilitate antibody transfer through milk.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-87831-w","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:04:13Z","timestamp":1738926253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of humoral immune response and milk antibody transfer in calves and lactating cows vaccinated with inactivated H5 avian influenza vaccine"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-9544","authenticated-orcid":false,"given":"Mohamed Samy","family":"Abousenna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermeen G.","family":"Shafik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Abotaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"87831_CR1","doi-asserted-by":"publisher","first-page":"341018","DOI":"10.1016\/j.aca.2023.341018","volume":"1251","author":"JH Kim","year":"2023","unstructured":"Kim, J. H. et al. Highly sensitive and label-free detection of influenza H5N1 viral proteins using affinity peptide and porous BSA\/MXene nanocomposite electrode. Anal. Chim. Acta. 1251, 341018. https:\/\/doi.org\/10.1016\/j.aca.2023.341018 (2023).","journal-title":"Anal. Chim. Acta"},{"key":"87831_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/v15020391","volume":"15","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Overexpression of TRIM16 reduces the titer of H5N1 highly pathogenic avian influenza virus and promotes the expression of antioxidant genes through regulating the SQSTM1-NRF2-KEAP1 Axis. Viruses 15, 391. https:\/\/doi.org\/10.3390\/v15020391 (2023).","journal-title":"Viruses"},{"key":"87831_CR3","doi-asserted-by":"publisher","first-page":"e1011135","DOI":"10.1371\/journal.ppat.1011135","volume":"19","author":"D Scheibner","year":"2023","unstructured":"Scheibner, D. et al. Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza a viruses. PLoS Pathog. 19, e1011135. https:\/\/doi.org\/10.1371\/journal.ppat.1011135 (2023).","journal-title":"PLoS Pathog"},{"key":"87831_CR4","doi-asserted-by":"publisher","first-page":"102638","DOI":"10.1016\/j.tmaid.2023.102638","volume":"55","author":"J Charostad","year":"2023","unstructured":"Charostad, J. et al. A comprehensive review of highly pathogenic avian influenza (HPAI) H5N1: an imminent threat at doorstep. Travel Med. Infect. Dis. 55, 102638. https:\/\/doi.org\/10.1016\/j.tmaid.2023.102638 (2023).","journal-title":"Travel Med. Infect. Dis."},{"issue":"4","key":"87831_CR5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3201\/eid2904.221538","volume":"29","author":"W Puryear","year":"2023","unstructured":"Puryear, W. et al. Highly pathogenic avian influenza A(H5N1) virus outbreak in New England Seals, United States. Emerg. Infect. Dis. 29 (4), 786\u2013791. https:\/\/doi.org\/10.3201\/eid2904.221538 (2023).","journal-title":"Emerg. Infect. Dis."},{"issue":"12","key":"87831_CR6","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3201\/eid2912.230464","volume":"29","author":"EJ Elsmo","year":"2023","unstructured":"Elsmo, E. J. et al. Highly pathogenic avian influenza A(H5N1) virus clade 2.3.4.4b infections in Wild Terrestrial mammals, United States, 2022. Emerg. Infect. Dis. 29 (12), 2451\u20132460. https:\/\/doi.org\/10.3201\/eid2912.230464 (2023).","journal-title":"Emerg. Infect. Dis."},{"issue":"5","key":"87831_CR7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3201\/eid2805.220318","volume":"28","author":"SN Bevins","year":"2022","unstructured":"Bevins, S. N. et al. Intercontinental Movement of highly pathogenic avian influenza A(H5N1) clade 2.3.4.4 virus to the United States, 2021. Emerg. Infect. Dis. 28 (5), 1006\u20131011. https:\/\/doi.org\/10.3201\/eid2805.220318 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"87831_CR8","unstructured":"United States Department of Agriculture Animal and Plant Health Inspection Service. Federal and state veterinary, public health agencies share update on HPAI detection in Kansas, Texas dairy herds. 2024 [cited 2024 Apr 30]. https:\/\/www.aphis.usda.gov\/news\/agency-announcements\/federal-state-veterinary-public-health-agencies-share-update-hpai"},{"key":"87831_CR9","doi-asserted-by":"publisher","DOI":"10.3201\/eid3007.240508","author":"ER Burrough","year":"2024","unstructured":"Burrough, E. R. et al. Highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b virus infection in domestic dairy cattle and cats, United States, 2024. Emerg. Infect. Dis. https:\/\/doi.org\/10.3201\/eid3007.240508 (2024).","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"87831_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/pathogens12010090","volume":"12","author":"Z Mosaad","year":"2023","unstructured":"Mosaad, Z. et al. Emergence of highly pathogenic avian influenza a virus (H5N1) of Clade 2.3.4.4b in Egypt, 2021\u20132022. Pathogens 12 (1), 90. https:\/\/doi.org\/10.3390\/pathogens12010090 (2023).","journal-title":"Pathogens"},{"issue":"5","key":"87831_CR11","doi-asserted-by":"publisher","first-page":"taad032","DOI":"10.1093\/jtm\/taad032","volume":"30","author":"A Bruno","year":"2023","unstructured":"Bruno, A. et al. First case of human infection with highly pathogenic H5 avian influenza a virus in South America: a new zoonotic pandemic threat for 2023? J. Travel Med. 30 (5), taad032. https:\/\/doi.org\/10.1093\/jtm\/taad032 (2023).","journal-title":"J. Travel Med."},{"key":"87831_CR12","doi-asserted-by":"publisher","unstructured":"Pulit-Penaloza, J. A. et al. Highly pathogenic avian influenza A(H5N1) virus of clade 2.3.4.4b isolated from a human case in Chile causes fatal disease and transmits between co-housed ferrets. Emerg. Microbes Infect. 2332667. https:\/\/doi.org\/10.1080\/22221751.2024.2332667 (2024).","DOI":"10.1080\/22221751.2024.2332667"},{"key":"87831_CR13","unstructured":"Centers for Disease Control and Prevention. Current H5N1 Bird Flu Situation in dairy cows. [cited 2024 Apr 30]. (2024). https:\/\/www.cdc.gov\/flu\/avianflu\/mammals.htm"},{"key":"87831_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.12688\/gatesopenres.13171.1","volume":"4","author":"V Guyonnet","year":"2020","unstructured":"Guyonnet, V. & Peters, A. R. Are current avian influenza vaccines a solution for smallholder poultry farmers? Gates Open. Res. 4, 122. https:\/\/doi.org\/10.12688\/gatesopenres.13171.1 (2020).","journal-title":"Gates Open. Res."},{"issue":"3","key":"87831_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/vaccines11030593","volume":"11","author":"P Dey","year":"2023","unstructured":"Dey, P. et al. Immune Control of Avian Influenza Virus Infection and its Vaccine Development. Vaccines 11 (3), 593. https:\/\/doi.org\/10.3390\/vaccines11030593 (2023).","journal-title":"Vaccines"},{"issue":"9","key":"87831_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/vaccines11091397","volume":"11","author":"SH Mahmoud","year":"2023","unstructured":"Mahmoud, S. H. et al. Immunogenicity and Cross-protective Efficacy Induced by an inactivated recombinant avian influenza A\/H5N1 (Clade 2.3.4.4b) vaccine against Co-circulating Influenza A\/H5Nx viruses. Vaccines 11 (9), 1397. https:\/\/doi.org\/10.3390\/vaccines11091397 (2023).","journal-title":"Vaccines"},{"key":"87831_CR17","unstructured":"World Organization for Animal Health. (WOAH)\u2013 Minimum requirements for the production and quality control of vaccines. In: World Organization for Animal Health. Manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds, bees). Paris: WOAH. Chapter 2.3.4. pp. 1\u201312. (2022). Available at: https:\/\/www.woah.org\/en\/what-we-do\/standards\/codes-and-manuals\/terrestrial-manual-online-access\/"},{"issue":"2","key":"87831_CR18","first-page":"51","volume":"29","author":"MA Mahmoud","year":"2020","unstructured":"Mahmoud, M. A. et al. The effect of spirulina algae on the immune response of SPF chickens to commercial inactivated Newcastle vaccine in poultry. VacciMonitor 29 (2), 51\u201357 (2020). https:\/\/vaccimonitor.finlay.edu.cu\/index.php\/vaccimonitor\/article\/view\/235","journal-title":"VacciMonitor"},{"key":"87831_CR19","unstructured":"World Organization for Animal Health. (WOAH)\u2013 AVIAN INFLUENZA (INCLUDING INFECTION WITH HIGH PATHOGENICITY AVIAN INFLUENZA VIRUSES). In: World Organization for Animal Health. Manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds, bees). Paris: WOAH. Chapter 3.3.4. pp. 1\u201326. (2025). Available at: https:\/\/www.woah.org\/en\/what-we-do\/standards\/codes-and-manuals\/terrestrial-manual-online-access\/"},{"issue":"10","key":"87831_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2903\/j.efsa.2023.8271","volume":"21","author":"EFSA AHAW Panel (EFSA Panel on Animal Health and Animal Welfare), European Union Reference Laboratory for Avian Influenza","year":"2023","unstructured":"EFSA AHAW Panel (EFSA Panel on Animal Health and Animal Welfare), European Union Reference Laboratory for Avian Influenza et al. Vaccination of poultry against highly pathogenic avian influenza \u2013 part 1. Available vaccines and vaccination strategies. EFSA J. 21 (10), 1\u201387. https:\/\/doi.org\/10.2903\/j.efsa.2023.8271 (2023).","journal-title":"EFSA J."},{"key":"87831_CR21","doi-asserted-by":"publisher","first-page":"108689","DOI":"10.1016\/j.vetmic.2020.108689","volume":"245","author":"J Hamdi","year":"2020","unstructured":"Hamdi, J. et al. Development and evaluation of an inactivated lumpy skin disease vaccine for cattle. Vet. Microbiol. 245, 108689. https:\/\/doi.org\/10.1016\/j.vetmic.2020.108689 (2020).","journal-title":"Vet. Microbiol."},{"issue":"11","key":"87831_CR22","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.14202\/vetworld.2020.2493-2501","volume":"13","author":"JI Cahyani","year":"2020","unstructured":"Cahyani, J. I., Widyarini, S. & Wibowo, M. H. Comparative safety and efficacy of two bivalent vaccines containing Newcastle disease LaSota and avian influenza H9N2 sidrap isolate formulated with different oil adjuvants. Veterinary World. 13 (11), 2493\u20132501 (2020). http:\/\/www.veterinaryworld.org\/13\/November-2020\/28.pdf","journal-title":"Veterinary World"},{"issue":"7","key":"87831_CR23","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/S2095-3119(22)63904-2","volume":"21","author":"ZX Ying","year":"2022","unstructured":"Ying, Z. X. et al. Hua-lan. Protective efficacy of an H5\/H7 trivalent inactivated vaccine (H5-Re13, H5-Re14, and H7-Re4 strains) in chickens, ducks, and geese against newly detected H5N1, H5N6, H5N8, and H7N9 viruses. J. Integr. Agric. 21 (7), 2086\u20132094. https:\/\/doi.org\/10.1016\/S2095-3119(22)63904-2 (2022).","journal-title":"J. Integr. Agric."},{"issue":"4","key":"87831_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4142\/jvs.2009.10.4.323","volume":"10","author":"DS Song","year":"2009","unstructured":"Song, D. S. et al. Evaluation of a competitive ELISA for antibody detection against avian influenza virus. J. Vet. Sci. 10 (4), 323\u2013329. https:\/\/doi.org\/10.4142\/jvs.2009.10.4.323 (2009).","journal-title":"J. Vet. Sci."},{"issue":"7","key":"87831_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/avj.12188","volume":"92","author":"SR Lanyon","year":"2014","unstructured":"Lanyon, S. R., McCoy, R., Bergman, E. & Reichel, M. P. Milk as a diagnostic sample for a commercially available ELISA to identify bovine viral diarrhoea (BVD) antibodies in dairy herds. Aust Vet. J. 92 (7), 269\u2013273. https:\/\/doi.org\/10.1111\/avj.12188 (2014).","journal-title":"Aust Vet. J."},{"issue":"38","key":"87831_CR26","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1016\/j.vaccine.2023.07.076","volume":"41","author":"J Mo","year":"2023","unstructured":"Mo, J., Spackman, E. & Swayne, D. E. Prediction of highly pathogenic avian influenza vaccine efficacy in chickens by comparison of in vitro and in vivo data: a meta-analysis and systematic review. Vaccine 41 (38), 5507\u20135517. https:\/\/doi.org\/10.1016\/j.vaccine.2023.07.076 (2023).","journal-title":"Vaccine"},{"key":"87831_CR27","unstructured":"Nermeen, G. et al. : Efficacy of a Commercial Local Trivalent Foot and Mouth Disease (FMD) Vaccine against Recently Isolated O-EA3, Inter J Vet Sci, 2019, 8(1): 35\u201338. (2019). https:\/\/www.ijvets.com\/pdf-files\/Volume-8-no-1-2019\/35-38.pdf"},{"key":"87831_CR28","unstructured":"Abousenna, M. S. Emergency evaluation for existing vaccine against Recently Isolated Foot and Mouth Disease Virus type SAT2 in Egypt 2018. VacciMonitor (2022). 31(1):9\u201314 https:\/\/vaccimonitor.finlay.edu.cu\/index.php\/vaccimonitor\/article\/view\/288"},{"key":"87831_CR29","unstructured":"Nermeen, G. S. et al. Efficacy of current vaccines against foot and mouth disease virus type a South America (Venezuela) recently isolated in Egypt in 2022. VacciMonitor, 2024; 33, e023324. https:\/\/vaccimonitor.finlay.edu.cu\/index.php\/vaccimonitor\/article\/view\/1055"},{"issue":"3","key":"87831_CR30","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.21931\/RB\/2021.01.03.12","volume":"6","author":"GS Nermeen","year":"2021","unstructured":"Nermeen, G. S. et al. Comparative study between lumpy skin disease virus and sheep pox virus vaccines against recent field isolate of lumpy skin disease virus. Revista Bionatura. 6 (3), 1955\u20131959. https:\/\/doi.org\/10.21931\/RB\/2021.01.03.12 (2021).","journal-title":"Revista Bionatura"},{"key":"87831_CR31","doi-asserted-by":"publisher","unstructured":"Kristensen, C., Jensen, H. E., Trebbien, R., Webby, R. J. & Larsen, L. E. The avian and human influenza a virus receptors sialic acid (SA)-\u03b12,3 and SA-\u03b12,6 are widely expressed in the bovine mammary glanPreprint at bioRxiv. (2024). https:\/\/doi.org\/10.1101\/2024.05.03.592326","DOI":"10.1101\/2024.05.03.592326"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87831-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87831-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87831-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:04:18Z","timestamp":1738926258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87831-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87831"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87831-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4627508\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"4637"}}